newsfilter
← Latest News
GlobeNewswire·

Supernus to Participate in Two Upcoming Investor Conferences

ROCKVILLE, Md., March 04, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous